ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · IEX Real-Time Price · USD
13.75
+0.29 (2.12%)
At close: Mar 28, 2024, 4:00 PM
14.00
+0.25 (1.82%)
After-hours: Mar 28, 2024, 5:37 PM EDT

ORIC Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Selling, General & Admin
25.6125.0922.0113.425.733.35
Research & Development
85.1761.6856.8635.9222.8419.03
Other Operating Expenses
05024.8400
Operating Expenses
110.7891.7778.8774.1928.5722.37
Operating Income
-110.78-91.77-78.87-74.19-28.57-22.37
Other Expense / Income
-10.08-2.65-0.16-0.48-1.69-1.01
Pretax Income
-100.7-89.12-78.72-73.7-26.88-21.36
Net Income
-100.7-89.12-78.72-73.7-26.88-21.36
Shares Outstanding (Basic)
5140382222
Shares Outstanding (Diluted)
5140382222
Shares Change
29.75%4.48%72.97%1055.26%9.53%-
EPS (Basic)
-1.96-2.25-2.07-3.36-14.15-12.32
EPS (Diluted)
-1.96-2.25-2.07-3.36-14.15-12.32
Free Cash Flow
-86.54-77.22-60.48-45.94-24.3-21.21
Free Cash Flow Per Share
-1.68-1.95-1.59-2.09-12.79-12.23
EBITDA
-99.67-88.16-77.82-72.73-25.86-20.46
Depreciation & Amortization
1.030.970.90.971.030.9
EBIT
-100.7-89.12-78.72-73.7-26.88-21.36
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).